Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jul 17;8(18):4792–4802. doi: 10.1182/bloodadvances.2024013468

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 3. — Outcomes of patients with MDS transplanted with PTCY vs ATG. (A) OS was 60% (95% CI, 52-72) for patients who underwent a MUD transplant and received PTCY, 53% (95% CI, 42-63) for patients who underwent a MMUD transplant and received PTCY, 52% (95% CI, 48-57) for patients who underwent a MUD transplant and received ATG, and 41% (95% CI, 34-49) for patients who underwent a MMUD transplant and received ATG (P = .004). (B) PFS was 56% (95% CI, 45-67) for patients who underwent a MUD transplant and received PTCY, 49% (95% CI, 38-60) for patients who underwent a MMUD transplant and received PTCY, 46% (95% CI, 42-51) for patients who underwent a MUD transplant and received ATG, and 37% (95% CI, 30-44) for patients who underwent a MMUD transplant and received ATG (P = .007). (C) GRFS was 35% (95% CI, 25-45) for patients who underwent a MUD transplant and received PTCY, 36% (95% CI, 25-46) for patients who underwent a MMUD transplant and received PTCY, 32% (95% CI, 28-37) for patients who underwent a MRD transplant and received ATG, and 26% (95% CI, 19-33) for patients who underwent a MMUD transplant and received ATG (P = .09). (D) RI was 22% (95% CI, 12-31) for patients who underwent a MUD transplant and received PTCY, 23% (95% CI, 14-32) for patients who underwent a MMUD transplant and received PTCY, 26% (95% CI, 22-29) for patients who underwent a MUD transplant and received ATG, and 24% (95% CI, 18-31) for patients who underwent a MMUD transplant and received ATG (P = .7). (E) NRM was 22% (95% CI, 14-30) for patients who underwent a MUD transplant and received PTCY, 28% (95% CI, 19-37) for patients who underwent a MMUD transplant and received PTCY, 28% (95% CI, 24-32) for patients who underwent a MUD transplant and received ATG, and 39% (95% CI, 32-46) for patients who underwent a MMUD transplant and received ATG (P = .009) when stratified by donor type (MUD vs MMUD). Numbers below the graph show the number of patients at risk.